Shigenobu Kanba
Shigenobu Kanba publishes mostly in Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology, on topics such as Schizophrenia research and treatment, Tryptophan and brain disorders and Bipolar Disorder and Treatment.
- World rank
- #279,631 of 7,710,434 ranked researchers
- Rank in Japan
- #2,337 of 383,136
- Works
- 516
- Citations
- 25k
- Citations per work
- 49.2
What does Shigenobu Kanba research?
Shigenobu Kanba's work is mostly in Neuroscience (19%), Medicine (14%), Psychology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else27653.5%
- Life Sciences12424.0%
- Neuroscience10019.4%
- Biochemistry, Genetics and Molecular Biology244.6%
- Health Sciences7214.0%
- Medicine7214.0%
- Social Sciences448.5%
- Psychology448.5%
- 1Psychiatry and Mental health14% of their works
- 2Cognitive Neuroscience10% of their works
- 3Clinical Psychology8% of their works
- 4Biological Psychiatry5% of their works
- 5Cellular and Molecular Neuroscience5% of their works
- 6Molecular Biology5% of their works
Research topics
- Schizophrenia research and treatment
- Tryptophan and brain disorders
- Bipolar Disorder and Treatment
- Neuroinflammation and Neurodegeneration Mechanisms
- Treatment of Major Depression
- Stress Responses and Cortisol
- Child and Adolescent Psychosocial and Emotional Development
- Youth Substance Use and School Attendance
Which keywords describe Shigenobu Kanba's research?
The keywords of their largest research topics: Depression, Microglia, Neuroinflammation, Neurobiology, Antipsychotic Drugs, Neurocognitive Deficits, Immune Activation and Tryptophan Metabolism.
- Truancy
- Psychopathology
- Stress
- Neurodegeneration
- Astrocytes
- Prevalence
- Tryptophan Metabolism
- Neurocognitive Deficits
- Neurobiology
- Microglia
- Depression
- Neuroinflammation
- Antipsychotic Drugs
- Immune Activation
- Bipolar Spectrum Disorder
- Antidepressant
- Ketamine
- Brain
- Emotion Regulation
- School Absenteeism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Depression1824 topics
- Microglia1162 topics
- Neuroinflammation1162 topics
- Neurobiology902 topics
- Antipsychotic Drugs701 topic
- Neurocognitive Deficits701 topic
- Immune Activation651 topic
- Tryptophan Metabolism651 topic
- Bipolar Spectrum Disorder541 topic
- Prevalence541 topic
- Antidepressant511 topic
- Astrocytes511 topic
- Ketamine511 topic
- Neurodegeneration511 topic
- Brain361 topic
- Stress361 topic
- Emotion Regulation301 topic
- Psychopathology301 topic
- School Absenteeism271 topic
- Truancy271 topic
Where does Shigenobu Kanba work?
Shigenobu Kanba's main affiliation in the publication record is Kyushu University, Japan.
How many publications and citations does Shigenobu Kanba have?
OpenAlex counts 516 works and 25,411 citations for Shigenobu Kanba, an h-index of 82, ranking #279,631 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shigenobu Kanba. Posts are plain text and can be reported.